Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing
Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60